Stockscreener 앱 받기
112.47
0.79%
0.88
시간 외 거래:
112.48
0.01
+0.01%
Abbott Laboratories 주식(ABT)의 최신 뉴스
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Exact Sciences stock enters new chapter after Abbott acquisition - Ad-hoc-news.de
Abbott Agrees to $670 Million Settlement in Premature Infant Formula Litigation - finance.biggo.com
Analyst Raises Abbott Price Target to $135 on Strengthening Cancer Diagnostics Growth and Successful Exact Sciences Integration - TipRanks
TD Cowen raises Abbott Labs stock price target on cancer diagnostics growth - Investing.com
Abbott Laboratories settles multitude of infant formula legal claims - Yahoo Finance
Abbott Bypasses Appeals Process To Settle Ongoing Premature Infant Formula Litigation - Yahoo Finance
Abbott agreed to pay $670 million to settle preterm baby formula lawsuits - qz.com
Abbott Laboratories stock holds firm after Q2 beat - Ad-hoc-news.de
Abbott Laboratories to pay $670 million to settle cases, claims over its formula for premature babies - Times West Virginian
True North Advisors LLC Trims Stake in Abbott Laboratories $ABT - MarketBeat
Asset Advisors Investment Management LLC Reduces Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Exchange Traded Concepts LLC Has $6.85 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Stock Position Raised by Financial & Tax Architects LLC - MarketBeat
Capital Investment Advisory Services LLC Sells 12,335 Shares of Abbott Laboratories $ABT - MarketBeat
ABN Amro Investment Solutions Purchases 19,480 Shares of Abbott Laboratories $ABT - MarketBeat
Alecta Tjanstepension Omsesidigt Acquires 153,500 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Inks $670M Deal To End Some Preterm Formula Claims - Law360
Abbott Will Pay $670 Million To End 2,000 Infant Formula Claims - NDTV Profit
Did Abbott’s Q2 Beat and Profit Hike Just Shift Abbott Laboratories’ (ABT) Investment Narrative? - simplywall.st
Abbott to pay $670 million to settle some preterm infant formula cases - The Lufkin Daily News
Abbott Reaches $670 Million Settlement in Infant Formula Litigation - Devdiscourse
Can Abbott Laboratories (ABT)’s Instinct Sensor Give MiniMed Group (MMED) a Competitive Edge? - Yahoo Finance
Abbott Laboratories Reaches $670 Million Settlement in NEC Infant Formula Lawsuits - Kalkine Media
Abbott to Pay $670 Million to Settle Baby-Formula Litigation - WSJ
Abbott agrees to $670 million settlement of infant formula cases - The Lufkin Daily News
Abbott settles preterm formula litigation for $670 million By Investing.com - Investing.com Canada
Abbott's $670 Million Settlement Resolves Infant Formula Legal Claims - Devdiscourse
Abbott in $670M settlement for some NEC infant formula claims (ABT:NYSE) - Seeking Alpha
Abbott agrees to pay ~$670M to resolve Gill case and ~2,000 related preterm formula claims - TradingView
Abbott settles $670M lawsuits over preterm infa... - Pluang
Abbott Will Pay $670 Million to End 2,000 Infant Formula Claims - Bloomberg.com
Abbott reaches agreements to resolve a portion of litigation involving its specialty formulas for preterm infants - PR Newswire
Abbott pays $670 million to settle 2,000 baby formula claims - Crain's Chicago Business
MiniMed Ships MiniMed Flex With Abbott's Smallest Instinct Sensor - Yahoo! Finance Canada
Avricore and Abbott Labs sign UK pharmacy testing deal | 2026-08-20 | Investing News - Stockhouse
Mirae Asset Global Investments Co. Ltd. Raises Position in Abbott Laboratories $ABT - MarketBeat
Murphy Pohlad Asset Management LLC Purchases 12,140 Shares of Abbott Laboratories $ABT - MarketBeat
Citizens National Bank Trust Department Acquires 11,285 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott vs. Intuitive Surgical: Is Consistent Growth Better Than Premium Growth? - Yahoo Finance
Abbott settles appeal of $495 million infant formula verdict - Investing.com
Richard W. Allen of Georgia’s 12th district makes significant trades in Abbott Laboratories and Advanced Micro Devices - Investing.com India
Abbott Laboratories (ABT) Could Be 5% Undervalued Following MiniMed Pump Launch - simplywall.st
UnitedHealth Stock And 2 Dividend Names For Investors Seeking Stability - simplywall.st
Abbott settles appeal over $495 million infant formula verdict - Reuters
Abbott Laboratories posts 4.8% sales growth in Q2 2026, driven by nutrition, diagnostics, and devices. - Pluang
Here's How Abbott's Medical Devices Arm Acts as a Growth Catalyst - The Globe and Mail
Abbott Laboratories: Diagnostics And Medical Devices Fuel Next Growth Phase (Downgrade) - Seeking Alpha
The Smartest Dividend ETF to Buy With $500 Right Now - The Globe and Mail
5 questions on Abbott’s glucose-ketone sensors - MedTech Dive
Abbott Laboratories raises earnings outlook aft... - Pluang
Invesco Nasdaq Biotech vs. Invesco Pharma: How Do These ETFs Stack Up? - The Motley Fool
Abbott Laboratories: Reasonably Valued After Surge, But Still An Attractive Buy Long-Term - Seeking Alpha
IFP Advisors Inc Purchases 176,649 Shares of Abbott Laboratories $ABT - MarketBeat
Thomasville National Bank Acquires Shares of 19,194 Abbott Laboratories $ABT - MarketBeat
Smith & Nephew drops 3.5% as finance chief quits - Proactive Investors
Allied Investment Advisors LLC Buys 17,762 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
2.66%
자본화:
|
볼륨(24시간):